Figure 2.
Survival of EμMyc mice treated with cyclophosphamide or MLN8237. Mice each received cyclophosphamide (100 mg/kg/week via intraperitoneal injection), MLN8237 (50 mg/kg/day orally), or the combination of cyclophosphamide and MLN8237 when palpable tumors were first palpated. The control group received no treatment.